title: Reply to Egesta Lopci, Arturo Chiti, and Massimo Lazzeri's Letter to the Editor re: Laura Evangelista, Alberto Briganti, Stefano Fanti, et al. New Clinical Indications for18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature. Eur Urol 2016;70:161-75.
authors.affiliation: Nuclear Medicine and Molecular Imaging Unit, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy. Electronic address: laura.evangelista@ioveneto.it.
authors.forename: Laura
authors.initials: L
authors.lastname: Evangelista
authors.affiliation: Service of Nuclear Medicine, Policlinico S. Orsola-Malpighi, University of Bologna, Bologna, Italy.
authors.forename: Stefano
authors.initials: S
authors.lastname: Fanti
authors.affiliation: Nuclear Medicine Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Picchio
mesh_terms: D002794:Choline; D006801:Humans; D008297:Male; D049268:Positron-Emission Tomography; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000601:surgery*
chemical_list: D002794:Choline